Quantum Computing and Quantum Technologies in Drug Discovery and Therapeutics: Evidence, Benchmarking, and Translational Integration
Sarfaraz K Niazi · 2026
Read Quantum Computing and Quantum Technologies in Drug Discovery and Therapeutics: Evidence, Benchmarking, and Translational Integration by Sarfaraz K Niazi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13138275.txt.
Description
Quantum tools are often promised as drug discovery's next engine, with little proof attached. Sarfaraz Niazi writes a solo 2026 review that separates the three quantum families and grades each against classical competition.
Quantum computing for molecule simulation gets the hardest look: present machines are noisy, error fixes are limited, and claimed wins rarely face strong classical baselines. Quantum sensing and quantum materials fare better in his telling. The review also folds in device therapies that evolve beside drugs, from light therapy to focused ultrasound opening the blood-brain barrier. His verdict: sensing and devices carry near-term clinical value, while computing stays a hypothesis generator until fault-tolerant machines arrive.
Catalog record
| CREATOR | Sarfaraz K Niazi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |